Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Board Meeting Outcome for Allotment Of 9,00,000 Convertible Warrants On Preferential Basis To The Promoters Of The Company

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and pursuant to the approval of the members obtained at the Extra-ordinary General Meeting held on 30th September, 2024 by means of Special Resolution and approval of the members obtained by way of Postal Ballot dated 3rd November, 2024 by means of ordinary resolution and 'In-Principal Approval' obtained from BSE Limited, the Board of Directors of the Company have, at its meeting held on 18th December, 2024 at 3.00 p.m. and concluded at 6.15 p.m., has inter-alia considered and approved the allotment of 9,00,000 convertible warrants of Rs.10/- each at a price of Rs.169.83, aggregating to Rs.15,28,47,000/- on preferential basis to the persons belonging to Promoter Category.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases